Nasus Pharma Ltd. Financial Flexibility Index
Nasus Pharma Ltd. financial flexibility index. Nasus Pharma Ltd. (NSRX) has a Financial Flexibility Index of -2.19x as of December 2025. Free cash flow of $-4.90 Million (operating CF $-4.92 Million minus capex $14.00K) represents -2% of total liabilities ($2.24 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Nasus Pharma Ltd. (2022–2025)
Financial flexibility index of Nasus Pharma Ltd. from 2022 to 2025. Historical Financial Flexibility Index trend for Nasus Pharma Ltd. across 4 annual periods. Explore cash flow to debt ratio of Nasus Pharma Ltd. to assess how comfortably operating cash covers total debt obligations.
Nasus Pharma Ltd. Financial Flexibility Index by Year (2022–2025)
Nasus Pharma Ltd. financial flexibility index by year from 2022 to 2025. Year-by-year free cash flow to debt coverage for Nasus Pharma Ltd.. For the full cash flow conversion analysis, see Nasus Pharma Ltd. cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.19x | $-4.90 Million | $-4.92 Million | $2.24 Million | ▼ -1195.8% |
| 2024 | -0.17x | $-665.00K | $-665.00K | $3.93 Million | ▲ +30.2% |
| 2023 | -0.24x | $-1.03 Million | $-1.03 Million | $4.24 Million | ▲ +35.8% |
| 2022 | -0.38x | $-1.21 Million | $-1.21 Million | $3.20 Million | — |